[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AT252264B - Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates - Google Patents

Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates

Info

Publication number
AT252264B
AT252264B AT240465A AT240465A AT252264B AT 252264 B AT252264 B AT 252264B AT 240465 A AT240465 A AT 240465A AT 240465 A AT240465 A AT 240465A AT 252264 B AT252264 B AT 252264B
Authority
AT
Austria
Prior art keywords
pure
production
hyaluronic acid
highly viscous
acid preparation
Prior art date
Application number
AT240465A
Other languages
English (en)
Inventor
Gerhard Dr Billek
Original Assignee
Etapharm Chem Pharm Lab Ges M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etapharm Chem Pharm Lab Ges M filed Critical Etapharm Chem Pharm Lab Ges M
Priority to AT240465A priority Critical patent/AT252264B/de
Priority to FR27849A priority patent/FR1456687A/fr
Priority to US534632A priority patent/US3396081A/en
Priority to CH378866A priority patent/CH485855A/de
Priority to NL6603433A priority patent/NL6603433A/xx
Priority to GB11510/66A priority patent/GB1088304A/en
Priority to DE1966E0031253 priority patent/DE1617447B1/de
Application granted granted Critical
Publication of AT252264B publication Critical patent/AT252264B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT240465A 1965-03-17 1965-03-17 Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates AT252264B (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT240465A AT252264B (de) 1965-03-17 1965-03-17 Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
FR27849A FR1456687A (fr) 1965-03-17 1965-08-10 Procédé de préparation d'un acide hyaluronique de forte viscosite
US534632A US3396081A (en) 1965-03-17 1966-03-16 Hyaluronic acid preparation and method of producing same
CH378866A CH485855A (de) 1965-03-17 1966-03-16 Verfahren zur Herstellung eines reinen, hochviskosen Hyaluronsäurepräparates
NL6603433A NL6603433A (de) 1965-03-17 1966-03-16
GB11510/66A GB1088304A (en) 1965-03-17 1966-03-16 Method of producing a pure, highly viscous hyaluronic acid preparation
DE1966E0031253 DE1617447B1 (de) 1965-03-17 1966-03-16 Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT240465A AT252264B (de) 1965-03-17 1965-03-17 Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates

Publications (1)

Publication Number Publication Date
AT252264B true AT252264B (de) 1967-02-10

Family

ID=3533724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT240465A AT252264B (de) 1965-03-17 1965-03-17 Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates

Country Status (6)

Country Link
US (1) US3396081A (de)
AT (1) AT252264B (de)
CH (1) CH485855A (de)
DE (1) DE1617447B1 (de)
GB (1) GB1088304A (de)
NL (1) NL6603433A (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132217A (en) * 1978-03-31 1979-10-15 Sunooden Kk Treating agent for autonomic disorder
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IE57931B1 (en) * 1983-10-11 1993-05-19 Fidia Spa Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
NO160722C (no) * 1983-11-25 1989-05-24 Miles Inc Fremgangsmaate for fremstilling av ultraren hyaluronsyre.
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5099013A (en) * 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
IL78720A (en) * 1985-05-09 1990-01-18 Hill David Cullis Preparation of high-purity hyaluronic acid from synovial fluid
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
GB2228736A (en) * 1989-02-10 1990-09-05 Sterivet Lab Ltd Cosmetic formulation
JPH02215707A (ja) * 1989-02-15 1990-08-28 Chisso Corp 皮膚化粧料
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
CA2553381C (en) * 2004-01-20 2011-03-22 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8466128B2 (en) * 2007-01-30 2013-06-18 Cypress Pharmaceuticals, Inc. Hyaluronate compositions
US8609634B2 (en) 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US9579341B2 (en) 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
EP2337536B1 (de) 2008-10-02 2020-08-12 L.R. R & D Ltd. Wundverband mit schnittstellenschicht
US20100247606A1 (en) * 2009-03-25 2010-09-30 Allergan, Inc. Intraocular sustained release drug delivery systems and methods for treating ocular conditions
IT201700008651A1 (it) 2017-01-26 2018-07-26 Beauty System Pharma Ltd Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
US11129862B2 (en) 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2662076A (en) * 1948-02-03 1953-12-08 Searle & Co Hyaluronidase inhibitors and the production thereof
US2599172A (en) * 1948-11-29 1952-06-03 Searle & Co Sulfuric acid esters of hyaluronic acid and processes for the production thereof
US3020204A (en) * 1960-05-11 1962-02-06 American Cyanamid Co Process for preparing augmentative intrinsic factor concentrate

Also Published As

Publication number Publication date
US3396081A (en) 1968-08-06
GB1088304A (en) 1967-10-25
CH485855A (de) 1970-02-15
DE1617447B1 (de) 1970-09-24
NL6603433A (de) 1966-09-19

Similar Documents

Publication Publication Date Title
AT252264B (de) Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
AT281424B (de) Verfahren zur Herstellung von neuen Kunststoffen
AT303261B (de) Verfahren zur Herstellung eines Zahnpflegemittels
AT300344B (de) Verfahren zur Herstellung eines Mischpolymerisates
AT289040B (de) Verfahren zur Herstellung eines Trägerkatalysators
CH434180A (de) Verfahren zur Herstellung eines Schichtstoffes
AT255769B (de) Verfahren zur Herstellung eines neuen Kunststoffes
AT290857B (de) Verfahren zur Herstellung eines Schichtstoffes
AT270874B (de) Verfahren zur Herstellung eines Zahnpflegemittels
AT305491B (de) Verfahren zur Herstellung eines neuen Kombinationspräparates
AT284797B (de) Verfahren zur Herstellung eines Trägerkatalysators
AT269356B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT288592B (de) Verfahren zur Herstellung eines neuen pharmazeutischen Präparates
AT285065B (de) Verfahren zur Herstellung eines neuen Pentacosapeptids
AT310942B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT267174B (de) Verfahren zur Herstellung neuer Polymerisationsprodukte
CH459162A (de) Verfahren zur Herstellung eines wasserstoffhaltigen Polyfluorbenzols
AT311571B (de) Verfahren zur Herstellung eines neuen 6α-Methyl-19-nor-progesterons
AT257167B (de) Verfahren zur Herstellung neuer Polymerisationsprodukte
CH445436A (de) Verfahren zur Herstellung eines Schichtstoffes
CH434182A (de) Verfahren zur Herstellung eines Schichtstoffes
CH537915A (de) Verfahren zur Herstellung eines neuen Östratriols
AT297920B (de) Verfahren zur Herstellung eines Arzneimittels
AT262935B (de) Verfahren zur Herstellung von Natriumborhydrid
CH486104A (de) Verfahren zur Herstellung eines quasi-homogenen Gebildes